{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:08:40Z","timestamp":1761181720190,"version":"build-2065373602"},"reference-count":283,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T00:00:00Z","timestamp":1641081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.sjbs.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:39:25Z","timestamp":1641555565000},"page":"2033-2046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review"],"prefix":"10.1016","volume":"29","author":[{"given":"A.S.","family":"Vickram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Thanigaivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Anbarasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nibedita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Karunakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/OLQ.0000000000000352","article-title":"Assessing trends in chlamydia positivity and gonorrhea incidence and their associations with the incidence of pelvic inflammatory disease and ectopic pregnancy in Washington state 1988\u20132010","volume":"43","author":"Moore","year":"2016","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b0010","article-title":"Human Overpopulation: Impact on Environment","volume":"738(632):1","author":"Uniyal","year":"2016","journal-title":"Environ. Issues Surrounding Hum. Overpopulation."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/humrep\/deaa031","article-title":"Early provision of intrauterine contraception as part of abortion care\u20145-year results of a randomised controlled trial","volume":"35","author":"Pohjoranta","year":"2020","journal-title":"Hum. Reprod."},{"issue":"10110","key":"10.1016\/j.sjbs.2022.01.006_b0020","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(17)31794-4","article-title":"Global, regional, and subregional classification of abortions by safety, 2010\u201314: estimates from a Bayesian hierarchical model","volume":"390","author":"Ganatra","year":"2017","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0025","first-page":"1005","article-title":"Female Temporary Contraceptive Method: Availability and Its Effects","volume":"2","author":"Dahal","year":"2017","journal-title":"J. Community Med. Health. Care"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0030","article-title":"Survey of condom use among college students","volume":"9","author":"Kidan","year":"2017","journal-title":"Ethiopian J. Health Devel, (EJHD)"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0035","article-title":"Determinants of condom use among Agaro High School students using behavioral models","volume":"18","author":"Girma","year":"2017","journal-title":"Ethiopi. J. Heal. Devel, (EJHD)"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1728-4465.2001.00053.x","article-title":"Correlates of sexual activity and condom use among secondary-school students in urban Peru","volume":"32","author":"Magnani","year":"2007","journal-title":"Stud. Fam. Plann."},{"key":"10.1016\/j.sjbs.2022.01.006_b0045","first-page":"13","article-title":"Unwanted Teenage Pregnancies: Sociological Model Based on Agents. Asia Pacifi","author":"Barroso","year":"2016","journal-title":"J. Soci. Behavi. Sci."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"issue":"16","key":"10.1016\/j.sjbs.2022.01.006_b0055","first-page":"1958","article-title":"Birth Control Patch","volume":"296","author":"Hampton","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0060","first-page":"890","article-title":"Birth control patch","volume":"299","author":"Kuehn","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1468-2354.2008.00504.x","article-title":"Pill, patch, or shot? Subjective expectations and birth control choice","volume":"49","author":"Delavande","year":"2008","journal-title":"Int. Econ. Rev."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nm0218-118","article-title":"A shot at contraception. In India, a nonagenarian renews testing of a birth control vaccine","volume":"24","author":"Jayaraman","year":"2018","journal-title":"Nat Med."},{"year":"2014","series-title":"The birth control movement and American society: From private vice to public virtue","author":"Reed","key":"10.1016\/j.sjbs.2022.01.006_b0075"},{"key":"10.1016\/j.sjbs.2022.01.006_b0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2016.02.020","article-title":"Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device","volume":"226","author":"Murphy","year":"2016","journal-title":"J. Cont. Release"},{"key":"10.1016\/j.sjbs.2022.01.006_b0085","article-title":"Combined hormonal contraceptives use among women with contraindications according to the who criteria: A systematic review","author":"Houv\u00e8ssou","year":"2020","journal-title":"Sex. Reproductive Healthcare"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.07.059","article-title":"Contraceptive counseling and postpartum contraceptive use","volume":"212","author":"Zapata","year":"2015","journal-title":"Am. J. Obstetr. Gynecol."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jpc.12450","article-title":"Factors associated with consistent contraception and condom use among M\u0101ori secondary school students in New Zealand","volume":"50","author":"Clark","year":"2014","journal-title":"J. Paediat. Child Health"},{"key":"10.1016\/j.sjbs.2022.01.006_b0100","unstructured":"Beksinska, M., 2016. Expanding contraceptive options for women: the SILCS diaphragm."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-8384-7","article-title":"Effectiveness of the female condom in preventing HIV and sexually transmitted infections: a systematic review and meta-analysis","volume":"20","author":"Wiyeh","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0110","first-page":"13","article-title":"Fertility awareness methods: distinctive modern contraceptives","volume":"4","author":"Malarcher","year":"2016","journal-title":"Global Health: Sci. Pract."},{"key":"10.1016\/j.sjbs.2022.01.006_b0115","article-title":"Immediate postpartum insertion of intrauterine device for contraception","author":"Lopez","year":"2015","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15546128.2014.944736","article-title":"Outercourse: Exploring nonpenetrative forms of pleasurable safer sex","volume":"9","author":"Bakaroudis","year":"2014","journal-title":"Am. J. Sexual. Educat."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/2305-0500.217340","article-title":"Anti-VDAC3 recombinant antibody decreased human sperm motility and membrane integrity: A potential spermicide for contraception","volume":"6","author":"Susmiarsih","year":"2017","journal-title":"As. Paci. J. Reprod."},{"key":"10.1016\/j.sjbs.2022.01.006_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/OAJC.S288569","article-title":"Safer Conception and Family Planning Knowledge, Attitudes, and Practices Among Postpartum Women with HIV in Rural South Africa","volume":"12","author":"Mandell","year":"2021","journal-title":"Open Access J. Contraception"},{"key":"10.1016\/j.sjbs.2022.01.006_b0135","unstructured":"Edet, S.I., N.E. Samuel, A.E. Etim. Impact of Overpopulation on the Biological Diversity Conservation in Boki Local Government Area of Cross River State, Nigeria. Am. J. Environ. Eng., 20144(5) 94-8."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.07.025","article-title":"A progressive elimination strategy for screening meiotic inhibitors as novel contraceptives","volume":"106","author":"Hanna","year":"2016","journal-title":"Fertili. Sterili."},{"issue":"13","key":"10.1016\/j.sjbs.2022.01.006_b0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jama.2017.10302","article-title":"Work Progresses on Male Contraceptives, but Hurdles Remain","volume":"318","author":"Rubin","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0150","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/14712598.2015.1049943","article-title":"Advances in development of a contraceptive vaccine against human chorionic gonadotropin","volume":"15","author":"Talwar","year":"2015","journal-title":"Expert Opin. Biolo Therapy"},{"issue":"35","key":"10.1016\/j.sjbs.2022.01.006_b0155","first-page":"3907","article-title":"Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development","volume":"24","author":"Samoylova","year":"2017","journal-title":"Curr. Medi. Chem."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0160","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamapediatrics.2016.0007","article-title":"Long-acting reversible contraception and condom use among female US high school students: implications for sexually transmitted infection prevention","volume":"170","author":"Steiner","year":"2016","journal-title":"JAMA Pediatr."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0165","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.vaccine.2013.10.010","article-title":"Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections","volume":"32","author":"Brotman","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b0170","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2174\/1389201016666150505122422","article-title":"Nasal vaccines against Hepatitis B: An update","volume":"16","author":"Almeida","year":"2015","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1586\/14760584.2016.1155988","article-title":"Therapeutic vaccines for prostate cancer: recent advances and future directions","volume":"15","author":"Strauss","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.sjbs.2022.01.006_b0180","article-title":"Promising results in development of male contraception","volume":"128005","author":"Dominiak","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6510","key":"10.1016\/j.sjbs.2022.01.006_b0185","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.291.6510.1693","article-title":"Population study of causes, treatment, and outcome of infertility","volume":"291","author":"Hull","year":"1985","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0015-0282(97)81923-1","article-title":"Autoimmunogenicity of the human sperm protein Sp17 in vasectomised men and identification of linear B cell epitopes","volume":"67","author":"Lea","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.sjbs.2022.01.006_b0195","article-title":"Evaluation of multi-epitope recombinant protein as a candidate for a contraceptive vaccine","volume":"103325","author":"Mortazavi","year":"2021","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0897.1997.tb00199.x","article-title":"Sperm antigens and their use in the development of an immunocontraceptive","volume":"37","author":"Diekman","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0205","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002484R","article-title":"Sperm proteins and cancer-testis antigens are released by the seminiferous tubules in mice and men","volume":"35","author":"O'Donnell","year":"2021","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0210","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.18632\/oncotarget.2802","article-title":"Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets","volume":"6","author":"Mirandola","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.sjbs.2022.01.006_b0215","article-title":"Evaluation of multi-epitope recombinant protein as a candidate for a contraceptive vaccine","volume":"2021","author":"Mortazavi","year":"2021","journal-title":"J. Reprod. Immunol."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0220","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.87.14.5563","article-title":"Identification of a ZP3-binding protein on acrosome-intact mouse sperm by photoaffinity crosslinking","volume":"87","author":"Bleil","year":"1990","journal-title":"Proceed. Nat. Acad Sci."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0378(99)00005-4","article-title":"The potential use of sperm antigens as targets for immunocontraception; past, present and future","volume":"43","author":"Frayne","year":"1999","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/scipharm89010003","article-title":"Vaginal Administration of Contraceptives","volume":"89","author":"Jalalvandi","year":"2021","journal-title":"Scientia Pharmaceutica"},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0235","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/00003495-200565050-00002","article-title":"Contraceptive vaccines","volume":"65","author":"Naz","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-0378(98)00039-4","article-title":"Molecular basis of sperm\u2013egg interaction and the prospects for immunocontraception","volume":"40","author":"Kerr","year":"1998","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0245","series-title":"The Sperm","first-page":"171","author":"Sharma","year":"2017"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/aja.2008.59","article-title":"The antibody against a nuclear autoantigenic sperm protein can result in reproductive failure","volume":"11","author":"Wang","year":"2009","journal-title":"Asian J. Androl."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/asj.12538","article-title":"Requirement for nuclear autoantigenic sperm protein mRNA expression in bovine preimplantation development","volume":"87","author":"Nagatomo","year":"2016","journal-title":"Ani. Sci. J."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-0378(94)90027-2","article-title":"Antibodies to sperm-specific human FA-1 inhibiti in vitro fertilisation in rhesus monkeys: development of a simian model for testing of anti-FA-1 contraceptive vaccine","volume":"27","author":"Naz","year":"1994","journal-title":"J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/molehr\/3.6.507","article-title":"Characterisation and isolation of SOB2, a human sperm protein with a potential role in oocyte membrane binding","volume":"3","author":"Lefevre","year":"1997","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.sjbs.2022.01.006_b0270","unstructured":"Hay, B.A., Li, J. 2014. California Institute of Technology. Antibody-mediated immunocontraception. U.S. Patent Application 14\/170,118."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0275","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14712598.3.5.829","article-title":"Contraceptive vaccines","volume":"3","author":"McLaughlin","year":"2003","journal-title":"Expert Opinin. Biol. Therapy"},{"issue":"9","key":"10.1016\/j.sjbs.2022.01.006_b0280","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mrd.22500","article-title":"Sugar-coated sperm: Unraveling the functions of the mammalian sperm glycocalyx","volume":"82","author":"Tecle","year":"2015","journal-title":"Mol. Reprod. Devel."},{"issue":"17","key":"10.1016\/j.sjbs.2022.01.006_b0285","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.vaccine.2005.07.007","article-title":"Characterisation of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9)","volume":"4","author":"Jagadish","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0290","article-title":"Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway","volume":"35(1):14","author":"Lou","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.sjbs.2022.01.006_b0295","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.theriogenology.2020.10.025","article-title":"Seminal antigenicity affects mitochondrial membrane potential and acrosome reaction ability of the spermatozoa during cryopreservation","volume":"159","author":"Archana","year":"2021","journal-title":"Theriogenology"},{"key":"10.1016\/j.sjbs.2022.01.006_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-319-40788-3_2","article-title":"Methods of analysis of sperm antigens related to fertility","author":"Shetty","year":"2017","journal-title":"Immune Infertil. Springer, Cham."},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0305","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/mrd.21092","article-title":"Izumo is part of a multiprotein family whose members form large complexes on mammalian sperm","volume":"76","author":"Ellerman","year":"2009","journal-title":"Mol. Reprod. Devel."},{"key":"10.1016\/j.sjbs.2022.01.006_b0310","doi-asserted-by":"crossref","unstructured":"Inoue, N.; M. Ikawa, A. Isotani and M. Okabe. The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs. Nature, 2005 434(7030):234.","DOI":"10.1038\/nature03362"},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0315","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/pro.2476","article-title":"Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide","volume":"23","author":"Naz","year":"2014","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0320","first-page":"254","article-title":"The molecular players of sperm\u2013egg fusion in mammals. Seminars Cell","volume":"17","author":"Rubinstein","year":"2006","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0325","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1095\/biolreprod66.3.735","article-title":"SAMP32, a testis-specific, isoantigenic sperm acrosomal membrane-associated protein","volume":"66","author":"Hao","year":"2002","journal-title":"Biol. Reprod"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0330","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0897.2007.00571.x","article-title":"Investigation of recombinant mouse sperm protein izumo as a potential immunocontraceptive antigen","volume":"59","author":"Wang","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0335","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/mrd.21027","article-title":"Immunocontraceptive potential of the Ig-like domain of Izumo","volume":"76","author":"Wang","year":"2009","journal-title":"Mol. Reprod. Devel."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0897.2009.00685.x","article-title":"In Vitro and In Vivo Studies Evaluating Recombinant Plasmid pCXN2-mIzumo as a Potential Immunocontraceptive Antigen","volume":"61","author":"An","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cells10010133","article-title":"Ligands and Receptors Involved in the Sperm-Zona Pellucida Interactions in Mammals","volume":"10","author":"Tumova","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.sjbs.2022.01.006_b0350","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1517\/13543776.2011.594042","article-title":"Reproductive component vaccine developments for contraceptive and non-contraceptive uses","volume":"21","author":"Ferro","year":"2011","journal-title":"Expert opin. Ther Pat."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mrd.20745","article-title":"Immunocontraception in mice using repeated, multi-antigen peptides: immunisation with purified recombinant antigens","volume":"75","author":"Hardy","year":"2008","journal-title":"Mol. Reprod. Devel."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0360","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0897.2011.01000.x","article-title":"Antisperm contraceptive vaccines: where we are and where we are going?","volume":"66","author":"Naz","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jri.2007.06.001","article-title":"Immunogenicity of a multi-component recombinant human acrosomal protein vaccine in female Macaca fascicularis","volume":"77","author":"Kurth","year":"2008","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0370","first-page":"131","article-title":"Comparative effects of GnRH and porcine zona pellucida (PZP) immunocontraceptive vaccines for controlling reproduction in white-tailed deer (Odocoileus virginianus)","volume":"60","author":"Curtis","year":"2002","journal-title":"Reproduction (Cambridge, England) Supplement"},{"key":"10.1016\/j.sjbs.2022.01.006_b0375","first-page":"177","article-title":"Porcine zona pellucida (PZP) immunocontraception of wild horses (Equus caballus) in Nevada: a 10 year study","volume":"60","author":"Turner","year":"2002","journal-title":"Reproduction(Cambridge, England) Supplement"},{"key":"10.1016\/j.sjbs.2022.01.006_b0380","first-page":"169","article-title":"Use of porcine zona pellucida (PZP) vaccine as a contraceptive agent in free-ranging tule elk (Cervus elaphus nannodes)","volume":"60","author":"Shideler","year":"2002","journal-title":"Reproduction (Cambridge, England) Supplement"},{"key":"10.1016\/j.sjbs.2022.01.006_b0385","first-page":"183","article-title":"Applications of pig zona pellucida immunocontraception to wildlife fertility control","author":"Kirkpatrick","year":"1996","journal-title":"J. Reprod. Fertil., Supplement."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0390","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jri.2006.04.006","article-title":"Biological control of vertebrate pests using virally vectored immunocontraception","volume":"71","author":"Hardy","year":"2006","journal-title":"J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0395","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1095\/biolreprod.102.012880","article-title":"Immunocontraception is induced in BALB\/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3","volume":"68","author":"Lloyd","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.sjbs.2022.01.006_b0400","first-page":"495","article-title":"Current status of virally vectored immunocontraception for biological control of mice","volume":"63","author":"Hardy","year":"2007","journal-title":"Soc. Reprod. Fertility Supplement"},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0405","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1071\/WR07041","article-title":"Prospects for virally vectored immunocontraception in the control of wild house mice (Mus domesticus)","volume":"34","author":"Redwood","year":"2008","journal-title":"Wildlife. Res."},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0410","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1071\/WR07050","article-title":"Prospects for the future: is there a role for virally vectored immunocontraception in vertebrate pest management?","volume":"34","author":"McLeod","year":"2008","journal-title":"Wildlife Res."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0415","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0897.2006.00379.x","article-title":"Immunocontraception of Florida Feral Swine with a Single-dose GnRH Vaccine","volume":"55","author":"Killian","year":"2006","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0420","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0897.2008.00616.x","article-title":"The Single-Shot GnRH Immunocontraceptive Vaccine (GonaCon\u2122) in White-Tailed Deer: Comparison of Several GnRH Preparations","volume":"60","author":"Miller","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0425","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/rda.12692","article-title":"Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice","volume":"51","author":"Han","year":"2016","journal-title":"Reprod. Domest. Animals"},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0430","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2015.01.076","article-title":"Design, synthesis and evaluation of a gonadotropin releasing hormone-based subunit vaccine in rams (Ovis aries)","volume":"33","author":"Goodwin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0435","first-page":"116:31","article-title":"Heberprovac, a therapeutic Gnrh based vaccine to treat advanced prostate cancer","author":"Barranco","year":"2015","journal-title":"Bju. International"},{"key":"10.1016\/j.sjbs.2022.01.006_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcam.2020.100493","article-title":"Efficacy of intratesticular glycerol injection as male cat contraception in comparison with two surgical approaches","volume":"42","author":"Madbouly","year":"2021","journal-title":"Topics Companion Animal Med."},{"key":"10.1016\/j.sjbs.2022.01.006_b0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.meatsci.2015.07.002","article-title":"Effect of vaccination against gonadotropin-releasing hormone (GnRH) in heavy male pigs for Italian typical dry-cured ham production","volume":"110","author":"Pinna","year":"2015","journal-title":"Meat Sci."},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0450","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/mrd.22743","article-title":"Novel Sperm and Gonadotropin-releasing Hormone-based Recombinant Fusion Protein: Achievement of 100% Contraceptive Efficacy by Co-immunization of Male and Female Mice","volume":"83","author":"Minhas","year":"2016","journal-title":"Mol. Reprod. Devel."},{"key":"10.1016\/j.sjbs.2022.01.006_b0455","first-page":"15 pages","article-title":"Immunocontraceptives: new approaches to fertility control","volume":"868196","author":"Kaur","year":"2014","journal-title":"BioMed. Res. Int., Article ID"},{"key":"10.1016\/j.sjbs.2022.01.006_b0460","article-title":"From the epididymis to the egg: participation of CRISP proteins in mammalian fertilisation. Asian","volume":"17(5):711","author":"Da Ros","year":"2015","journal-title":"J. Androl."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127508","article-title":"Construction of a catsper1 DNA vaccine and its antifertility effect on male mice","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0470","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1095\/biolreprod59.5.1029","article-title":"Potential contraceptive use of epididymal proteins: immunisation of male rats with epididymal protein DE inhibits sperm fusion ability","volume":"59","author":"Ellerman","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.sjbs.2022.01.006_b0475","first-page":"535","article-title":"Eppin: a molecular strategy for male contraception","volume":"65","author":"Wang","year":"2007","journal-title":"Soci. Reprod. Fertil. Suppl."},{"issue":"1\u20132","key":"10.1016\/j.sjbs.2022.01.006_b0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2005.12.039","article-title":"Eppin: an effective target for male contraception","volume":"250","author":"O'rand","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5699","key":"10.1016\/j.sjbs.2022.01.006_b0485","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.1099743","article-title":"Reversible immunocontraception in male monkeys immunised with eppin","volume":"306","author":"O'rand","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0490","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1095\/biolreprod.108.072942","article-title":"Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate","volume":"80","author":"O'Rand","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.sjbs.2022.01.006_b0495","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2015.11.004","article-title":"Non-hormonal male contraception: A review and development of an Eppin based contraceptive","volume":"157","author":"Michael","year":"2016","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.sjbs.2022.01.006_b0500","doi-asserted-by":"crossref","unstructured":"Nieschlag, E., Henke, A. Hopes for male contraception. The Lancet, 365(9459) 554-6.","DOI":"10.1016\/S0140-6736(05)70774-1"},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0505","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/humupd\/dmu036","article-title":"The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders","volume":"20","author":"Persani","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0510","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mrd.21265","article-title":"Integral role of GDF-9 and BMP-15 in ovarian function","volume":"78","author":"Otsuka","year":"2011","journal-title":"Mol. Reprod. Devel."},{"key":"10.1016\/j.sjbs.2022.01.006_b0515","series-title":"Site and risk factors of antisperm antibodies production in the male population","first-page":"133","author":"Marconi","year":"2017"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/andr.12436","article-title":"Increased risk of autoimmune disorders in infertile men: analysis of US claims data","volume":"6","author":"Brubaker","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/j.sjbs.2022.01.006_b0525","article-title":"Hexavalent Sperm-Binding IgG Antibody Released from Self-Dissolving Vaginal Film Enables Potent, On-Demand Non-Hormonal Female Contraception","author":"Shrestha","year":"2021","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0530","article-title":"Ureaplasma urealyticum and infertility","volume":"44","author":"Sturm","year":"1978","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0535","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/IAI.01171-06","article-title":"Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum","volume":"75","author":"Shi","year":"2007","journal-title":"Infect. Immunt."},{"year":"2014","series-title":"Immunology of the female genital tract","author":"Weissenbacher","key":"10.1016\/j.sjbs.2022.01.006_b0540"},{"key":"10.1016\/j.sjbs.2022.01.006_b0545","first-page":"235","article-title":"Immune responses in the epididymis: implications for immunocontraception","author":"Beagley","year":"1998","journal-title":"J. Reprod. Fertil.-Supp."},{"issue":"6 Suppl","key":"10.1016\/j.sjbs.2022.01.006_b0550","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1097\/00006454-198611010-00012","article-title":"Evaluation of the role of Ureaplasma urealyticum in infertility","volume":"5","author":"Taylor-Robinson","year":"1986","journal-title":"Pediatr. Infect. Dis."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0555","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future prospects for new vaccines against sexually transmitted infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0560","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13584-017-0153-4","article-title":"On the implications of desexualising vaccines against sexually transmitted diseases: health policy challenges in a multicultural society","volume":"6","author":"Velan","year":"2017","journal-title":"Israel J. Health Policy Res."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0565","first-page":"62","article-title":"Sexually Transmitted Disease Testing and Uptake of Human Papillomavirus Vaccine in a Large Online Survey of US Men Who Have Sex With Men at Risk for HIV Infection","volume":"44","author":"Kahle","year":"2012","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170773","article-title":"Costing of National STI Program implementation for the global STI control strategy for the health sector, 2016\u20132021","volume":"12","author":"Korenromp","year":"2016","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002333","article-title":"A Collection on the prevention, diagnosis, and treatment of sexually transmitted infections: Call for research papers","volume":"14","author":"Low","year":"2017","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0580","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/INF.0000000000001548","article-title":"Effect of combination vaccines on Hepatitis B vaccine compliance in children in the United States","volume":"36","author":"Kurosky","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.sjbs.2022.01.006_b0585","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-59952-6_12","author":"Van Damme","year":"2017","journal-title":"Hepatitis A Vaccines. Pediatr. Vaccines Vaccinat."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0590","first-page":"256","article-title":"Prevalent vaccination practices among Indian Allopathic non-pediatrician doctors for their own children: A proxy indicator of updated knowledge about childhood immunisation","volume":"10","author":"Gupta","year":"2017","journal-title":"Al. Ameen. J. Med. Sci."},{"key":"10.1016\/j.sjbs.2022.01.006_b0595","article-title":"Vaccines for preventing hepatitis B in healthcare workers (an updated protocol). The Cochrane","author":"Borch","year":"2017","journal-title":"Library."},{"year":"2017","series-title":"A 2-Part Study Examining; Hepatitis B Vaccination Rates Among High-risk Adults and the Influence of Education on Knowledge and Awareness of Hepatitis B and the Use of Vaccines as a Safe, Preventative Measure Among University of MS Students","author":"Wilson","key":"10.1016\/j.sjbs.2022.01.006_b0600"},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0605","article-title":"Prevalence of Hepatitis B Virus Seromarkers and Associated Risk Factors in Young Healthy Individuals in Bangladesh: Implications for Preventive Strategies","volume":"17","author":"Hasan","year":"2017","journal-title":"Hepatitis Monthly"},{"issue":"26","key":"10.1016\/j.sjbs.2022.01.006_b0610","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.vaccine.2016.03.111","article-title":"The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps","volume":"34","author":"Gottlieb","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0615","doi-asserted-by":"crossref","unstructured":"Nahmias, A.J., Keyserlin, H., Lee, F.K. Herpes simplex viruses 1 and 2. In Viral infections of humans. Springer, Boston, MA. 1989 393-417.","DOI":"10.1007\/978-1-4613-0705-1_14"},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b0620","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"Looker","year":"2008","journal-title":"Bull. World Health Organ."},{"issue":"21","key":"10.1016\/j.sjbs.2022.01.006_b0625","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.1128\/JVI.74.21.9916-9927.2000","article-title":"Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray","volume":"74","author":"Stingley","year":"2000","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0630","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1128\/JCM.02235-16","article-title":"Stability studies on dry swabs and wet mailed swabs for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Aptima assays","volume":"55","author":"Moncada","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0635","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/cid\/cix975","article-title":"Trends and predictors of syphilis prevalence in the general population: Global pooled analyses of 1103 prevalence measures including 136 million syphilis tests","volume":"66","author":"Smolak","year":"2017","journal-title":"Clin. Infect. Dis."},{"year":"1992","series-title":"Infectious diseases of humans: dynamics and control","author":"Anderson","key":"10.1016\/j.sjbs.2022.01.006_b0640"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies","volume":"13","author":"Smith","year":"1984","journal-title":"Int. J. Epidemiol."},{"issue":"suppl 1","key":"10.1016\/j.sjbs.2022.01.006_b0650","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1136\/sti.78.suppl_1.i14","article-title":"The geographical and temporal evolution of sexually transmitted disease epidemics","volume":"78","author":"Garnett","year":"2002","journal-title":"Sex. Transm. Infect."},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0655","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0966-842X(00)89010-1","article-title":"Modelling HIV vaccination","volume":"3","author":"McLean","year":"1995","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0660","doi-asserted-by":"crossref","unstructured":"Linares, L.O., Shankar, V., Diaz, A.; Nucci-Sack, A., Strickler H.D., Peake, K. The Association between Cumulative Psychosocial Risk and Cervical HPV Infection Among Female Adolescents in a Free Vaccination Program. J. Develop. Behavi. Pediatr. (JDBP), 36(8):620.","DOI":"10.1097\/DBP.0000000000000178"},{"key":"10.1016\/j.sjbs.2022.01.006_b0665","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.epidem.2015.02.003","article-title":"The racial disparities in STI in the US: Concurrency, STI prevalence, and heterogeneity in partner selection","volume":"11","author":"Hamilton","year":"2015","journal-title":"Epidemics"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0670","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/10717544.2021.1912211","article-title":"Clinical comparative study of optimized metronidazole loaded lipid nanocarrier vaginal emulgel for management of bacterial vaginosis and its recurrence","volume":"28","author":"Badawi","year":"2021","journal-title":"Drug Delivery"},{"key":"10.1016\/j.sjbs.2022.01.006_b0675","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00007435-200011000-00007","article-title":"The epidemiology of bacterial sexually transmitted disease: the problems and opportunities of a cure","volume":"27","author":"Garnett","year":"2000","journal-title":"Sex. Transm. Dis."},{"issue":"Supplement_1","key":"10.1016\/j.sjbs.2022.01.006_b0680","article-title":"Role of herd immunity in determining the effect of vaccines against sexually transmitted disease","volume":"191","author":"Garnett","year":"2005","journal-title":"J. infect. Diseases"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0685","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3356\/JRR-16-32.1","article-title":"No substitute for survival: Perturbation analyses using a Golden Eagle population model reveal limits to managing for take","volume":"51","author":"Tack","year":"2017","journal-title":"J. Raptor Res."},{"issue":"16","key":"10.1016\/j.sjbs.2022.01.006_b0690","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.vaccine.2006.01.048","article-title":"Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes","volume":"24","author":"Brabin","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0695","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/1468-0009.12080","article-title":"Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program","volume":"92","author":"Frost","year":"2014","journal-title":"The Milbank Quarterly"},{"issue":"9631","key":"10.1016\/j.sjbs.2022.01.006_b0700","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(08)60953-8","article-title":"New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data","volume":"371","author":"Dunkle","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002481","article-title":"Sexually transmitted infections-Research priorities for new challenges","volume":"14","author":"Low","year":"2017","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0710","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/2047-3095.12074","article-title":"Latino adolescent perspectives toward sexually transmitted infection educational programs","volume":"27","author":"Lee","year":"2016","journal-title":"Int. J. Nur. Knowl."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b0715","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2105\/AJPH.2017.303814","article-title":"Small-group randomised controlled trial to increase condom use and HIV testing among Hispanic\/Latino gay, bisexual, and other men who have sex with men","volume":"107","author":"Rhodes","year":"2017","journal-title":"Am. J. Public Healt."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0720","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.vaccine.2013.07.087","article-title":"Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines","volume":"32","author":"Gottlieb","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0725","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/cid\/ciu888","article-title":"A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis","volume":"60","author":"Ganesan","year":"2014","journal-title":"Clin. Infect. Diseases"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0730","first-page":"107","article-title":"Comparison of doxycycline and benzathine penicillin G for the treatment of early syphilis","volume":"25","author":"Xiao","year":"2017","journal-title":"Acta dermatovenerologica Croatica."},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b0735","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/cid\/cix611","article-title":"A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China","volume":"65","author":"Cao","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0740","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkv379","article-title":"Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection","volume":"71","author":"Yang","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"suppl8","key":"10.1016\/j.sjbs.2022.01.006_b0745","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Workowski","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"suppl_8","key":"10.1016\/j.sjbs.2022.01.006_b0750","doi-asserted-by":"crossref","first-page":"S818","DOI":"10.1093\/cid\/civ714","article-title":"Management of adult syphilis: key questions to inform the2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines","volume":"61","author":"Ghanem","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0755","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.annemergmed.2016.08.405","article-title":"Implementation of an Emergency Department Syphilis and HIV Point-of-Care Screening Process During an Outbreak of Syphilis in Detroit, MI in Collaboration With the Infectious Disease Department and the Centers for Disease Control and Prevention","volume":"68","author":"Manteuffel","year":"2016","journal-title":"Ann. Emergen. Medi."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0760","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.1038\/nmicrobiol.2016.245","article-title":"Origin of modern syphilis and emergence of a pandemic Treponema pallidum cluster","volume":"2","author":"Arora","year":"2017","journal-title":"Nature Microbiol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0765","article-title":"Contemporary syphilis is characterised by rapid global spread of pandemic Treponema pallidum lineages","author":"Beale","year":"2021","journal-title":"medRxiv."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0770","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1017\/S0950268814002830","article-title":"Syphilis: antibiotic treatment and resistance","volume":"143","author":"Stamm","year":"2015","journal-title":"Epidemiol. Infect."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0775","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4269\/ajtmh.15-0316","article-title":"Macrolide resistance in the syphilis spirochete, Treponema pallidum ssp. pallidum: Can we also expect macrolide-resistant yaws strains?","volume":"93","author":"Smajs","year":"2015","journal-title":"Am. J. Tropic. Medi. Hygiene"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0780","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12889-016-2966-4","article-title":"Poor awareness of syphilis prevention and treatment knowledge among six different populations in south China","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.sjbs.2022.01.006_b0785","unstructured":"Ellington, R.D., 2016 Sexual Health Education Policy: Influences on the Implementation of Sexual Health Education Programs (Doctoral dissertation, Walden University)."},{"key":"10.1016\/j.sjbs.2022.01.006_b0790","unstructured":"World Health Organization, 2017. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0795","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.vaccine.2013.09.053","article-title":"Current status of syphilis vaccine development: need, challenges, prospects","volume":"32","author":"Cameron","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0800","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14760584.2016.1203262","article-title":"Vaccine development for syphilis","volume":"16","author":"Lithgow","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"15","key":"10.1016\/j.sjbs.2022.01.006_b0805","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1017\/S0950268816001643","article-title":"Epidemiological impact of a syphilis vaccine: a simulation study","volume":"144","author":"Champredon","year":"2016","journal-title":"Epidemiol. Infect."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0810","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.vaccine.2013.11.007","article-title":"The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease","volume":"32","author":"Garnett","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b0815","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1071\/SH14156","article-title":"Public health interventions to control syphilis","volume":"12","author":"Peterman","year":"2015","journal-title":"Sex. Health"},{"key":"10.1016\/j.sjbs.2022.01.006_b0820","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2016.11.031","article-title":"Re-evaluating the sensitivity of the rabbit infectivity test for Treponema pallidum in modern era","volume":"464","author":"Tong","year":"2017","journal-title":"Clin. Chimi. Acta."},{"key":"10.1016\/j.sjbs.2022.01.006_b0825","doi-asserted-by":"crossref","DOI":"10.1002\/9781118962954.ch16","article-title":"Paleoepidemiological and biocultural approaches to ancient disease: the origin and antiquity of syphilis","author":"Zuckerman","year":"2016","journal-title":"New Directions in Biocultural Anthropol."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b0830","first-page":"308","article-title":"Artificial immunisation of rabbits against syphilis. I. Effect of increasing doses of treponemes given by the intramuscular route","volume":"45","author":"Metzger","year":"1969","journal-title":"British J. Vener. Dis."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0835","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in Experimental Syphilis: VI. Successful Vaccination of Rabbits with Treponema Pallidum, Nichols Strain, Attenuated by \u03b3-Irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0840","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunisation with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0845","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1346-8138.12818","article-title":"Multiple primary syphilis on the lip, nipple\u2013areola and penis: An immunohistochemical examination of Treponema pallidum localisation using an anti-T. pallidum antibody","volume":"42","author":"Fukuda","year":"2015","journal-title":"J. Dermatol."},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0850","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.vaccine.2013.08.032","article-title":"Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agencies","volume":"32","author":"Dodet","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0855","doi-asserted-by":"crossref","unstructured":"Kotloff, K.L., Platts-Mills, J.A., Nasrin, D., Roose, A., Blackwelder, W.C. and Levine, M.M. Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques. Vaccine, 35(49):6783-9.","DOI":"10.1016\/j.vaccine.2017.07.036"},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0860","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijmm.2015.08.022","article-title":"Fluorescence in situ hybridisation for the identification of Treponema pallidum in tissue sections","volume":"305","author":"Petrich","year":"2015","journal-title":"Int. J. Medi. Microbiol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0865","first-page":"1","article-title":"Combined Intravitreal and Systemic Antibiotic Therapy in a Patient with Syphilitic Uveitis","volume":"22","author":"Sood","year":"2017","journal-title":"Ocular Immunol. Inflammat."},{"key":"10.1016\/j.sjbs.2022.01.006_b0870","doi-asserted-by":"crossref","DOI":"10.1097\/OLQ.0000000000000830","article-title":"Biomedical Research Priorities for Modern Syphilis Clinical Management, Diagnosis, and Vaccines: Overview and Commentary for Unit 1","author":"Kersh","year":"2018","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0875","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15761\/GVI.1000104","article-title":"Vaccines and the looming threat of syphilis","volume":"1","author":"Ambrose","year":"2016","journal-title":"Glob. Vaccines Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0880","first-page":"8:14273","article-title":"A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum. Nature","author":"Lithgow","year":"2017","journal-title":"Communications"},{"issue":"14","key":"10.1016\/j.sjbs.2022.01.006_b0885","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2013.08.067","article-title":"Vaccines against Gonorrhea: current status and future challenges","volume":"32","author":"Jerse","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0890","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against Gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol. Cell. Proteom."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0895","doi-asserted-by":"crossref","DOI":"10.2217\/fmb-2017-0262","article-title":"Could vaccination against Neisseria gonorrhoeae be on the horizon?","volume":"13","author":"Russell","year":"2018","journal-title":"Future Microbiol."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b0900","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/CVI.00230-16","article-title":"Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop \u201cGonorrhea Vaccines: the Way Forward\u201d","volume":"23","author":"Wetzler","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b0905","unstructured":"Dubensky, T.W.; N.A. Hosken; S.H. Robbins and M.D. Moore. Inventors; IMMUNE DESIGN CORP, assignee. Vaccines for HSV-2. United States patent 2018 US 9,895,435.20."},{"key":"10.1016\/j.sjbs.2022.01.006_b0910","unstructured":"Dubensky, Jr.,T.W., Hosken, N.A., Robbins, S.H., Moore, M.D. Inventors; IMMUNE DESIGN CORP, assignee. Vaccines for HSV-2. United States patent 2017 US 9,555,099.31."},{"issue":"26","key":"10.1016\/j.sjbs.2022.01.006_b0915","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0920","unstructured":"Long, D., Flechtner, J., Skoberne, M. Siber, G.R. Inventors; Genocea Biosciences Inc, assignee. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response. United States patent US 9,895,436."},{"issue":"9","key":"10.1016\/j.sjbs.2022.01.006_b0925","doi-asserted-by":"crossref","first-page":"e02257","DOI":"10.1128\/JVI.02257-16","article-title":"Prophylactic herpes simplex virus 2 (HSV-2) vaccines adjuvanted with stable emulsion and toll-like receptor 9 agonist induce a robust HSV-2-specific cell-mediated immune response, protect against symptomatic disease, and reduce the latent viral reservoir","volume":"91","author":"Hensel","year":"2017","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b0930","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/ajt.14683","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"18","author":"Dooling","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.sjbs.2022.01.006_b0935","unstructured":"Brekke, O.H., Fredriksen, A.B., Areffard, A., Lindeberg, M.M., 2018. Inventors; Vaccibody As, assignee. Vaccines against hpv. United States patent US 9,901,635.27."},{"key":"10.1016\/j.sjbs.2022.01.006_b0940","doi-asserted-by":"crossref","unstructured":"Di Mario, S., Basevi, V., Lopalco, P.L., Balduzzi, S., D\u2019Amico, R. and Magrini, N., 2015. Are the two human papillomavirus vaccines really similar? A systematic review of available evidence: efficacy of the two vaccines against HPV. J. Immunol. Res., Article ID 435141:13.","DOI":"10.1155\/2015\/435141"},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0945","article-title":"Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer\u2014Could a Schistosomiasis Vaccine be the Third? PLoS Negl","volume":"9","author":"Hsieh","year":"2015","journal-title":"Tropic. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b0950","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ebiom.2016.08.005","article-title":"The potential benefits of HPV vaccination in previously infected women","volume":"10","author":"Schiller","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.sjbs.2022.01.006_b0955","doi-asserted-by":"crossref","unstructured":"Agarwal, M., Trimble, C. Cancer Vaccines for HPV Malignancies. InOncoimmunology, 2018, pp. 263-274. Springer, Cham.","DOI":"10.1007\/978-3-319-62431-0_15"},{"key":"10.1016\/j.sjbs.2022.01.006_b0960","unstructured":"Oh, S., Zurawski, S., Zurawski, G. Inventors; Baylor Research Institute, assignee. Novel vaccines against hpv and hpv-related diseases. United States patent application US 15\/111,357."},{"key":"10.1016\/j.sjbs.2022.01.006_b0965","doi-asserted-by":"crossref","unstructured":"Best, S.R, S.I. Pa. The Role of Vaccines for HPV-Related Head and Neck Cancers. InHPV and Head and Neck Cancers, Springer, New Delhi, 2015 99-110.","DOI":"10.1007\/978-81-322-2413-6_7"},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b0970","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.OLQ.0000099160.26205.22","article-title":"Screening for Neisseria gonorrhoeae and Chlamydia trachomatis in men who have sex with men at male-only saunas","volume":"30","author":"Lister","year":"2003","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b0975","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development","volume":"71","author":"Rice","year":"2017","journal-title":"Ann. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b0980","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent Gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"New Eng. J. Medi."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b0985","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and Gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003","volume":"41","author":"Kent","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005611","article-title":"Antibiotic-resistant Neisseria gonorrhoeae spread faster with more treatment, not more sexual partners","volume":"12","author":"Fingerhuth","year":"2016","journal-title":"PLoS Pathogens"},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b0995","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/OLQ.0000000000000709","article-title":"Limited Empirical Data on Oropharyngeal Neisseria gonorrhoeae Among Men Who Have Sex With Men and Implications for Modeling","volume":"44","author":"Bernstein","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1000","article-title":"Sampling technique and detection rates of oropharyngeal and anorectal gonorrhoea using nucleic acid amplification tests in men who have sex with men","author":"Yang","year":"2017","journal-title":"Sex. Transm. Infect. Sextrans"},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b1005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/OLQ.0000000000000661","article-title":"Neisseria gonorrhoeae transmission among men who have sex with men: an anatomical site-specific mathematical model evaluating the potential preventive impact of mouthwash","volume":"44","author":"Zhang","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1010","doi-asserted-by":"crossref","unstructured":"Zhang, L., Regan, D.G., Chow, E.P., Gambhir, M., Cornelisse, V., Grulich, A., et al., 2017. O14. 4 Oropharyngeal transmission of neisseria gonorrhoeae among men who have sex with men and potential impacts of mouthwash A32-A33.","DOI":"10.1136\/sextrans-2017-053264.81"},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b1015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","article-title":"Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?","volume":"91","author":"Lewis","year":"2015","journal-title":"Sex. Transm. Infect."},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b1020","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/JCM.01186-16","article-title":"Neisseria gonorrhoeae bacterial DNA load in the pharynges and saliva of men who have sex with men","volume":"54","author":"Chow","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b1025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2334-14-43","volume":"14","author":"Nakashima","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b1030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/OLQ.0000000000000613","article-title":"Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010\u20132015","volume":"44","author":"Kreisel","year":"2017","journal-title":"Sex. Transm. Dis."},{"issue":"11","key":"10.1016\/j.sjbs.2022.01.006_b1035","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1473-3099(16)30157-8","article-title":"Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study","volume":"16","author":"De Silva","year":"2016","journal-title":"Lancet Infect. Diseases"},{"key":"10.1016\/j.sjbs.2022.01.006_b1040","article-title":"Predictors of Chlamydia trachomatis and Neisseria gonorrhea screening acceptance in a New York City school-based STD program","volume":"43","author":"Sarkar","year":"2016","journal-title":"Sex. Transm. Dis."},{"issue":"18","key":"10.1016\/j.sjbs.2022.01.006_b1045","first-page":"30011","article-title":"Prevalence of Chlamydia Trachomatis, Neisseria Gonorrhoeae, and Trichomonas Vaginalis Infection in Chilean Adolescents and Young Adults","volume":"S1083\u20133188","author":"Huneeus","year":"2018","journal-title":"J. Pediat. Adol. Gynecol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1050","article-title":"Planning health promotion programs: an intervention mapping approach","author":"Eldredge","year":"2016","journal-title":"John Wiley & Sons."},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b1055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40615-015-0194-8","article-title":"Incarcerated black women in the Southern USA: a narrative review of STI and HIV risk and implications for future public health research, practice, and policy","volume":"4","author":"Pelligrino","year":"2017","journal-title":"J. Racial Ethn. Health. Disparities"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b1060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1071\/SH16215","article-title":"Sex education: findings from the Second Australian Study of Health and Relationships","volume":"14","author":"Yeung","year":"2017","journal-title":"Sex. Health."},{"issue":"4","key":"10.1016\/j.sjbs.2022.01.006_b1065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/2373379916678234","article-title":"Sex Education Policy: Need for a Standard Definition of Medically Accurate Information","volume":"3","author":"Gonzalez","year":"2017","journal-title":"Pedagogy Health Promot."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1070","article-title":"Gonococcal culture and drug sensitivity pattern in patients with urethral discharge and vaginal discharge with cervicitis","volume":"13","author":"Lama","year":"2017","journal-title":"Post-Graduate Medical J. NAMS."},{"key":"10.1016\/j.sjbs.2022.01.006_b1075","first-page":"42(9):475","article-title":"Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis","author":"Gorgos","year":"2017","journal-title":"Sex. Transm. Diseases"},{"key":"10.1016\/j.sjbs.2022.01.006_b1080","volume":"1403\u20131420","author":"Igietseme","year":"2015","journal-title":"Mol. Med. Microbiol. (Second Edition)"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b1085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40779-016-0074-5","article-title":"Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections","volume":"3","author":"Bautista","year":"2016","journal-title":"Milit. Medi. Res."},{"issue":"11","key":"10.1016\/j.sjbs.2022.01.006_b1090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0956462416648585","article-title":"European guideline on the management of non-gonococcal urethritis","volume":"27","author":"Horner","year":"2016","journal-title":"Int. J. STD AIDS"},{"issue":"7","key":"10.1016\/j.sjbs.2022.01.006_b1095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/sextrans-2016-052950","article-title":"Neisseria gonorrhoeae DNA bacterial load in men with symptomatic and asymptomatic gonococcal urethritis","volume":"93","author":"Priest","year":"2017","journal-title":"Sex. Transm. Infect."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b1100","doi-asserted-by":"crossref","first-page":"S763","DOI":"10.1093\/cid\/civ755","article-title":"Advances in the understanding and treatment of male urethritis","volume":"61","author":"Bachmann","year":"2015","journal-title":"Clin. Infect. Diseases"},{"issue":"49","key":"10.1016\/j.sjbs.2022.01.006_b1105","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.14260\/Jemds\/2017\/810","article-title":"A study of co-infection with neisseria gonorrhoeae and chlamydia trachomatis in male urethritis","volume":"6","author":"Dudhipala","year":"2017","journal-title":"J Evol Medi Dent Sci."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/OLQ.0000000000000718","article-title":"Should asymptomatic men who have sex with men be screened for oropharyngeal chlamydia? Clinical outcomes from a cross-sectional study","volume":"45","author":"Ong","year":"2018","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1115","article-title":"Screening for Chlamydia trachomatis and Neisseria gonorrhoeae infection among asymptomatic men who have sex with men in Bangkok, Thailand","author":"Pattanasin","year":"2017","journal-title":"Int. J. STD & AIDS"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b1120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.1972.03200030077032","article-title":"Treatment of Gonorrhea","volume":"220","author":"Handsfield","year":"1972","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.sjbs.2022.01.006_b1125","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PEC.0000000000000631","article-title":"Acute Salpingitis in a Nonsexually Active Adolescent","volume":"31","author":"Fein","year":"2015","journal-title":"Pediat. Emergen. Care"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1130","first-page":"129","article-title":"Fallopian tubes\u2013literature review of anatomy and etiology in female infertility","volume":"8","author":"Briceag","year":"2015","journal-title":"J. Medi Life"},{"issue":"297","key":"10.1016\/j.sjbs.2022.01.006_b1135","first-page":"048","article-title":"Inventors; Medical Diagnostic Laboratories LLC, assignee. Antibiotic resistance profile for Neisseria gonorrhoeae and use of same in diagnosis and treatment of Gonorrhea","volume":"9","author":"Balashov","year":"2016","journal-title":"United States patent US"},{"issue":"9","key":"10.1016\/j.sjbs.2022.01.006_b1140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix450","article-title":"Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in Gonorrhea","volume":"216","author":"Tuite","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"36","key":"10.1016\/j.sjbs.2022.01.006_b1145","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.36.30335","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins","volume":"21","author":"Regnath","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.sjbs.2022.01.006_b1150","unstructured":"Rodriguez, C.A. Geographical Incidence of Antimicrobial Resistant Gonorrhea. Winter 12-16-2016."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00007435-197904000-00020","article-title":"Experience with various antibiotics for treatment of anorectal Gonorrhea","volume":"6","author":"Washington","year":"1979","journal-title":"Sex. Transm. Dis."},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b1160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2017.11037","article-title":"New Hope for a Gonorrhea Vaccine","volume":"318","author":"Abbasi","year":"2017","journal-title":"JAMA"},{"issue":"10102","key":"10.1016\/j.sjbs.2022.01.006_b1165","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b1170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1754.2010.01969.x","article-title":"Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic","volume":"48","author":"Lennon","year":"2012","journal-title":"J. Paediatr. Child Healt."},{"issue":"9816","key":"10.1016\/j.sjbs.2022.01.006_b1175","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study","volume":"379","author":"Santolaya","year":"2012","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.sjbs.2022.01.006_b1180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1071\/SH15009","article-title":"Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia","volume":"12","author":"Trembizki","year":"2015","journal-title":"Sex. Health"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b1185","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0005-2015","article-title":"Antigenic variation in bacterial pathogens","volume":"4","author":"Palmer","year":"2016","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.sjbs.2022.01.006_b1190","unstructured":"Lam, J. Genetic adaptation contributing to increased gonococcal fitness during vaginal infection of CEACAM-humanized mice (Doctoral dissertation, University of Toronto (Canada) 2017."},{"issue":"6","key":"10.1016\/j.sjbs.2022.01.006_b1195","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/1040841X.2015.1105782","article-title":"Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development","volume":"42","author":"Edwards","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1200","first-page":"6:22549","article-title":"Oral Immunisation of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage \u03a66 Induces Bactericidal Antibodies Against N. gonorrhoeae","author":"Piekarowicz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.sjbs.2022.01.006_b1205","doi-asserted-by":"crossref","unstructured":"Lao, A.H., Bonavida, B., 2016. Gonorrhea: Immune Escape and Immunotherapeutic Strategies. FIDT, 7(3-4), Begel House Inc.","DOI":"10.1615\/ForumImmunDisTher.2017020535"},{"key":"10.1016\/j.sjbs.2022.01.006_b1210","first-page":"26","article-title":"Aminomethyl spectinomycins as therapeutics for drug-resistant Gonorrhea and chlamydial co-infections","author":"Butler","year":"2018","journal-title":"Antimicrob. Agents Chemotherapy"},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/jiv024","article-title":"Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model","volume":"212","author":"Gulati","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.sjbs.2022.01.006_b1220","doi-asserted-by":"crossref","first-page":"e00898","DOI":"10.1128\/IAI.00898-16","article-title":"MetQ of Neisseria gonorrhoeae is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies","volume":"85","author":"Semchenko","year":"2017","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.sjbs.2022.01.006_b1225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182555","article-title":"Refinement of immunising antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae","volume":"12","author":"Shewell","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.sjbs.2022.01.006_b1230","doi-asserted-by":"crossref","first-page":"e02452","DOI":"10.1128\/mBio.02452-14","article-title":"Neisseria gonorrhoeae elicits extracellular traps in primary neutrophil culture while suppressing the oxidative burst","volume":"6","author":"Gunderson","year":"2015","journal-title":"MBio."},{"issue":"10","key":"10.1016\/j.sjbs.2022.01.006_b1235","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1128\/JB.02594-14","article-title":"Neisseria gonorrhoeae MutS affects pilin antigenic variation through mismatch correction and not by pilE guanine quartet binding","volume":"197","author":"Rotman","year":"2015","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.sjbs.2022.01.006_b1240","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11596-016-1589-4","article-title":"Opacity proteins of neisseria gonorrhoeae in lipooligosaccharide mutants lost ability to interact with neutrophil-restricted CEACAM3 (CD66d)","volume":"36","author":"Zhang","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol., [Med. Sci.]"},{"key":"10.1016\/j.sjbs.2022.01.006_b1245","article-title":"Biological feasibility and importance of a gonorrhea vaccine for global public health","author":"Vincent","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b1250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0000000000000450","article-title":"Neisseria gonorrhoeae vaccine development: hope on the horizon?","volume":"31","author":"Edwards","year":"2018","journal-title":"Curr. Opinion Infect. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/fmb-2017-0262","article-title":"Could vaccination against Neisseria gonorrhoeae be on the horizon?","author":"Russell","year":"2018","journal-title":"Future Microbiol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1260","first-page":"9","article-title":"The US military commitment to vaccine development: a century of successes and challenges","author":"Ratto-Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1270","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"issue":"Suppl. 5","key":"10.1016\/j.sjbs.2022.01.006_b1275","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1016\/j.vaccine.2012.04.106","article-title":"Human papillomavirus vaccines\u2014immune responses","volume":"30","author":"Stanley","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b1280","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3389\/fimmu.2018.02478","article-title":"Advances in designing and developing vaccines, drugs and therapeutic approaches to counter human papilloma virus","volume":"9","author":"Dadar","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1285","doi-asserted-by":"crossref","unstructured":"Anna Rosa Garbuglia, Daniele Lapa, Catia Sias , Maria Rosaria Capobianchi and Paola Del Porto. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease. Front. Immunol. 20 11:188.","DOI":"10.3389\/fimmu.2020.00188"},{"key":"10.1016\/j.sjbs.2022.01.006_b1290","unstructured":"Australian New Zealand Clinical Trials Registry. ANZTR identifier ACTRN12619001478101. Therapeutic Advances in Vaccines and Immunotherapy 8 MenGO: does the licensed meningococcal vaccine Bexsero\u00ae provide cross-protection against gonorrhoea in gay and bisexual men? https:\/\/www. anzctr.org.au\/Trial\/Registration\/TrialReview. aspx?id=376715. (accessed 31 October 2020)."},{"key":"10.1016\/j.sjbs.2022.01.006_b1295","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1300","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2019.02.022","article-title":"Non-pathogenic borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates","volume":"37","author":"Parveen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b1305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41426-018-0176-0","article-title":"Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.sjbs.2022.01.006_b1310","unstructured":"Centre for Disease Control and Prevention. The Tuskegee timeline, https:\/\/www.cdc.gov\/tuskegee\/ timeline.htm. (accessed 13 August 2019)."},{"key":"10.1016\/j.sjbs.2022.01.006_b1315","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/icb.2015.79","article-title":"A multisubunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-\u028f+ CMI responses protects against a genital infection in minipigs","volume":"94","author":"B\u00f8je","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1325","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3389\/fimmu.2017.01652","article-title":"Protective effect of the vaccine promoted neutralizing antibodies against the intracellular pathogen Chlamydia trachomatis","volume":"8","author":"Olsen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1330","unstructured":"Fattom AI. Development of a nanoemulsion based vaccine for Chlamydia infection. http:\/\/ grantome.com\/grant\/NIH\/R43-AI134168-01A1. (accessed 9 September 2019)."},{"key":"10.1016\/j.sjbs.2022.01.006_b1335","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2015.02.055","article-title":"Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine","volume":"33","author":"Karunakaran","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b1340","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.sjbs.2022.01.006_b1345","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/IAI.73.4.2005-2011.2005","article-title":"Antibiotic-free plasmid stabilization by operator repressor titration for vaccine delivery by using live Salmonella enterica serovar typhimurium","volume":"73","author":"Garmory","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.sjbs.2022.01.006_b1350","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated Chlamydial vaccine protects against trachoma in non-human primates","volume":"208","author":"Kari","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.sjbs.2022.01.006_b1355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection. Two randomized controlled trials","volume":"282","author":"Corey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.sjbs.2022.01.006_b1360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.282.4.379","article-title":"Herpes simplex virus vaccines \u2013 why don\u2019t antibodies protect?","volume":"282","author":"Mascola","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.sjbs.2022.01.006_b1365","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/315878","article-title":"Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs","volume":"182","author":"Strasser","year":"2000","journal-title":"J. Infect Dis."},{"key":"10.1016\/j.sjbs.2022.01.006_b1370","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2015.12.076","article-title":"Status of vaccine research and development of vaccines for herpes simplex virus","volume":"34","author":"Johnston","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2022.01.006_b1375","unstructured":"ClinicalTrials.gov. Identifier NCT02919306. Safety and efficacy study of vaccine schedule with Ad26.Mos.HIV and MVA-Mosaic in human immunodeficiency virus (HIV)-infected adults,https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02919306?term=vaccine&cond=Human+Immunodeficien cy+Virus&draw=2&rank=1. (accessed 20 March 2019)."},{"key":"10.1016\/j.sjbs.2022.01.006_b1380","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with Alvac and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"New Engl J. Med."},{"key":"10.1016\/j.sjbs.2022.01.006_b1385","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.sjbs.2022.01.006_b1390","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"Moldt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.sjbs.2022.01.006_b1395","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1128\/JVI.76.17.8769-8775.2002","article-title":"Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer","volume":"76","author":"Lewis","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2022.01.006_b1400","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/COH.0b013e328363d389","article-title":"Development of replication-competent viral vectors for HIV vaccine delivery","volume":"8","author":"Parks","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.sjbs.2022.01.006_b1405","unstructured":"Staples, J.E., Martin, S.W., Fischer M. Zika, 2019. Travel-related infections. In: Brunette, G.W., Nemhauser, J.B. (Eds.) CDC Yellow Book 2020: Health Information for International Travel New York: Oxford University Press."},{"key":"10.1016\/j.sjbs.2022.01.006_b1410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002611","article-title":"Sexual transmission of Zika virus and other flaviviruses a living systematic review","volume":"15","author":"Counotte","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.sjbs.2022.01.006_b1415","unstructured":"World Health Organization. Welcome to the WHO vaccine trial tracker, https:\/\/docs.google. com\/spreadsheets\/d\/19otvINcayJURCMg76xWO4KvuyedYbMZDcXqbyJGdcZM\/pubhtml (2019). (accessed 9 September 2020)."},{"key":"10.1016\/j.sjbs.2022.01.006_b1420","doi-asserted-by":"crossref","unstructured":"Sakkas, H., Bozidis, P., Giannakopoulos, X., et al. An update on sexual transmission of Zika virus. Pathogens 2018; 7: pii: E66.","DOI":"10.3390\/pathogens7030066"}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X22000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X22000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:17:29Z","timestamp":1761153449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X22000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":283,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1319562X22000067"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2022.01.006","relation":{},"ISSN":["1319-562X"],"issn-type":[{"type":"print","value":"1319-562X"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}